252 related articles for article (PubMed ID: 29722113)
1. Primary aldosteronism in patients with adrenal incidentaloma: Is screening appropriate for everyone?
Stavropoulos K; Imprialos KP; Katsiki N; Petidis K; Kamparoudis A; Petras P; Georgopoulou V; Finitsis S; Papadopoulos C; Athyros VG; Doumas M; Karagiannis A
J Clin Hypertens (Greenwich); 2018 May; 20(5):942-948. PubMed ID: 29722113
[TBL] [Abstract][Full Text] [Related]
2. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 1: Epidemiology of PA, who should be screened for sporadic PA?
Baguet JP; Steichen O; Mounier-Véhier C; Gosse P
Ann Endocrinol (Paris); 2016 Jul; 77(3):187-91. PubMed ID: 27087531
[TBL] [Abstract][Full Text] [Related]
3. Primary aldosteronism: emerging trends.
Galati SJ; Hopkins SM; Cheesman KC; Zhuk RA; Levine AC
Trends Endocrinol Metab; 2013 Sep; 24(9):421-30. PubMed ID: 23796656
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.
Rossi E; Regolisti G; Negro A; Sani C; Davoli S; Perazzoli F
Am J Hypertens; 2002 Oct; 15(10 Pt 1):896-902. PubMed ID: 12372677
[TBL] [Abstract][Full Text] [Related]
5. Who should be screened for primary aldosteronism? A comprehensive review of current evidence.
Huang WC; Lin YH; Wu VC; Chen CH; Siddique S; Chia YC; Tay JC; Sogunuru G; Cheng HM; Kario K
J Clin Hypertens (Greenwich); 2022 Sep; 24(9):1194-1203. PubMed ID: 36196469
[TBL] [Abstract][Full Text] [Related]
6. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism.
Kietsiriroje N; Wonghirundecha R; Suntornlohanakul O; Murray RD
Clin Endocrinol (Oxf); 2020 Mar; 92(3):196-205. PubMed ID: 31840266
[TBL] [Abstract][Full Text] [Related]
7. Primary Aldosteronism Screening Rates Differ with Sex, Race, and Comorbidities.
Turcu AF; Nhan W; Grigoryan S; Zhang L; Urban C; Liu H; Holevinski L; Zhao L
J Am Heart Assoc; 2022 Jul; 11(14):e025952. PubMed ID: 35861830
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, diagnosis and outcomes of treatment for primary aldosteronism.
Yang Y; Reincke M; Williams TA
Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101365. PubMed ID: 31837980
[TBL] [Abstract][Full Text] [Related]
9. Primary aldosteronism: who should be screened?
Monticone S; Viola A; Tizzani D; Crudo V; Burrello J; Galmozzi M; Veglio F; Mulatero P
Horm Metab Res; 2012 Mar; 44(3):163-9. PubMed ID: 22120135
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach.
Carey RM
Curr Cardiol Rep; 2016 Oct; 18(10):97. PubMed ID: 27566330
[TBL] [Abstract][Full Text] [Related]
11. Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
Vaidya A; Carey RM
J Clin Endocrinol Metab; 2020 Dec; 105(12):3771-83. PubMed ID: 32865201
[TBL] [Abstract][Full Text] [Related]
12. Problems in diagnostics of primary aldosteronism - analysis of the own data.
Myśliwiec J; Zukowski L; Grodzka A; Piłaszewicz A; Dragowski S; Piekut B; Nikołajuk A; Górska M
Endokrynol Pol; 2010; 61(1):2-5. PubMed ID: 20205097
[TBL] [Abstract][Full Text] [Related]
13. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
[TBL] [Abstract][Full Text] [Related]
14. Primary aldosteronism and hypertensive disease.
Mosso L; Carvajal C; González A; Barraza A; Avila F; Montero J; Huete A; Gederlini A; Fardella CE
Hypertension; 2003 Aug; 42(2):161-5. PubMed ID: 12796282
[TBL] [Abstract][Full Text] [Related]
15. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
16. The aldosterone/renin ratio as a screening test for primary aldosteronism.
Rayner BL; Opie LH; Davidson JS
S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
[TBL] [Abstract][Full Text] [Related]
17. Update on Primary Aldosteronism: Time to Screen All Hypertensives.
Memon SS; Bandgar T
J Assoc Physicians India; 2024 Jan; 72(1):11-12. PubMed ID: 38736067
[TBL] [Abstract][Full Text] [Related]
18. SFE/SFHTA/AFCE primary aldosteronism consensus: Introduction and handbook.
Amar L; Baguet JP; Bardet S; Chaffanjon P; Chamontin B; Douillard C; Durieux P; Girerd X; Gosse P; Hernigou A; Herpin D; Houillier P; Jeunemaitre X; Joffre F; Kraimps JL; Lefebvre H; Ménégaux F; Mounier-Véhier C; Nussberger J; Pagny JY; Pechère A; Plouin PF; Reznik Y; Steichen O; Tabarin A; Zennaro MC; Zinzindohoue F; Chabre O
Ann Endocrinol (Paris); 2016 Jul; 77(3):179-86. PubMed ID: 27315757
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of primary aldosteronism in primary care: a cross-sectional study.
Käyser SC; Deinum J; de Grauw WJ; Schalk BW; Bor HJ; Lenders JW; Schermer TR; Biermans MC
Br J Gen Pract; 2018 Feb; 68(667):e114-e122. PubMed ID: 29335324
[TBL] [Abstract][Full Text] [Related]
20. Determination of the aldosterone/renin ratio in 269 patients with adrenal incidentaloma.
Vierhapper H
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):518-21. PubMed ID: 17853335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
